Pathstone Holdings’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
20,923
+5,338
+34% +$249K ﹤0.01% 1387
2026
Q1
$564K Buy
15,585
+4,723
+43% +$198K ﹤0.01% 1701
2025
Q4
$512K Buy
+10,862
New +$459K ﹤0.01% 1741
2025
Q3
Sell
-20,604
Closed -$849K 2342
2025
Q2
$849K Buy
20,604
+15,450
+300% +$597K ﹤0.01% 1471
2025
Q1
$215K Sell
5,154
-995
-16% -$51.8K ﹤0.01% 2053
2024
Q4
$360K Buy
6,149
+2,231
+57% +$132K ﹤0.01% 1876
2024
Q3
$271K Buy
3,918
+333
+9% +$21.5K ﹤0.01% 2024
2024
Q2
$229K Buy
3,585
+687
+24% +$51.7K ﹤0.01% 2085
2024
Q1
$272K Buy
+2,898
New +$233K ﹤0.01% 1996

Other funds holding BRKR

Pathstone Holdings's BRKR Position: Q2 2026 in Review

Pathstone Holdings increased its Bruker (BRKR) stake by 34% in Q2 2026, buying an estimated $249K and bringing the position to 20,923 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Pathstone Holdings first reported a position in BRKR in Q1 2024 and has held it in 9 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Pathstone Holdings held 20,923 shares of Bruker worth $1.26M as of Q2 2026.
  • Pathstone Holdings bought 5,338 Bruker shares in Q2 2026, an estimated $249K.
  • Bruker made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1387 holding.
  • Pathstone Holdings first reported a position in Bruker in Q1 2024 and has held it in 9 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.